Related references
Note: Only part of the references are listed.Modulation of insulin-like growth factor (IGF)-I and IGF-Binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice
Jonathan D. Schertzer et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury
J. D. Schertzer et al.
GENE THERAPY (2006)
Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice
Jonathan D. Schertzer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Paul Gregorevic et al.
NATURE MEDICINE (2006)
Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice
LJ Harcourt et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
β2-agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle
JD Schertzer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Susceptibility to sarcomere injury induced by single stretches of maximally activated muscles of mdx mice
CM Consolino et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Heregulin ameliorates the dystrophic phenotype in mdx mice
TOB Krag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice
P Gregorevic et al.
MUSCLE & NERVE (2004)
Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy
GS Lynch
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2004)
Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration
P Gregorevic et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
ER Barton et al.
JOURNAL OF CELL BIOLOGY (2002)
Insulin-like growth factor-I (IGF-I) analogue, LR3IGF-I, ameliorates the loss of body weight but not of skeletal muscle during food restriction
FM Tomas
GROWTH HORMONE & IGF RESEARCH (2001)
Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice
J Reimann et al.
NEUROMUSCULAR DISORDERS (2000)
Share Paper
